Antibodies against the β subunit of voltage-dependent calcium channels in Lambert-Eaton myasthenic syndrome

Neuroscience

Volumn 90, Issue 1, 1999, Pages 269-277

  Raymond, C ^a   Walker, D ^a   Bichet, D ^a   Iborra, C ^a   Martin Moutot, N ^a   Seagar, M ^a   De Waard, M ^a  

^a INSERM   (France)

Author keywords

subunits; Calcium channels; Interaction sites; LEMS; Neuromuscular junction; Transmitter release

Indexed keywords

CALCIUM CHANNEL;

ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; EATON LAMBERT SYNDROME; HUMAN; NEUROMUSCULAR SYNAPSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANTIBODIES; CALCIUM CHANNELS; EPITOPES; HUMANS; IMMUNOGLOBULIN G; MYASTHENIA GRAVIS; PRECIPITIN TESTS;

EID: 0033043598     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00378-9     Document Type: Article

References (39)

1. Arsac C., Raymond C., Martin-Moutot N., Dargent B., Couraud F., Pouget J., Seager M. Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum. Ann. Neurol. 40:1996;695-700.
2. Birnbaumer L., Campbell K.P., Catterall W.A., Harpold M.M., Hofmann F., Horne W.A., Mori Y., Schwartz A., Snutch T.P., Tanabe T., Tsien R.W. The naming of voltage-gated calcium channels. Neuron. 13:1994;505-506.
3. 1A subunit of the P/Q-type calcium channel. Eur. molec. Biol. Org. J. 16:1997;4591-4596.
4. Clouston P.D., Saper C.B., Arbizu T., Johnston I., Lang B., Newsom-Davis J., Posner J.B. Paraneoplastic cerebellar degeneration. Neurology. 42:1992;1944-1950.
5. Dalmau J., Furneaux H.M., Gralla R.J., Kris M.G., Posner J.B. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer - a quantitative western blot analysis. Ann. Neurol. 27:1990;544-552.
6. David C., Solimena M., De Camilli P. Autoimmunity in Stiff-Man syndrome with breast cancer is targeted to the C-terminal region of human amphiphysin, a protein similar to the yeast proteins, Rvs167 and Rvs161. Fedn Eur. biochem. Socs Lett. 351:1994;73-79.
7. 1 subunits at the human and rat neuromuscular junction. J. Neurosci. 17:1997;6226-6235.
8. 2+ channels. J. biol. Chem. 270:1995;12056-12064.
9. De Waard M., Gurnett C. A. and Campbell K. P. (1996) Structural and functional diversity of voltage-activated calcium channels. In Ion Channels (ed. Narahashi T.), pp. 41-87. Plenum, New York.
10. El Far O., Marquèze B., Leveque C., Martin-Moutôt N., Lang B., Newsom-Davis J., Yoshida A., Takahashi M., Seagar M. Antigens associated with N- and L-type calcium channels in Lambert-Eaton myasthenic syndrome. J. Neurochem. 64:1995;1696-1702.
11. Flockerzi V., Oeken H.-J., Hofmann F., Pelzer D., Cavalie A., Trautwein W. Purified dihydropyridine-binding site from skeletal muscle t-tubules is a functional calcium channel. Nature. 323:1986;66-68.
12. Fukunaga H., Engel A.G., Lang B., Newsom-Davis J., Vincent A. Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. Proc. natn. Acad. Sci. U.S.A. 80:1983;7636-7640.
13. Garcia K.D., Beam K.G. Reduction of calcium currents by Lambert-Eaton syndrome sera: motoneurons are preferentially affected, and l-type currents are spared. J. Neurosci. 16:1996;4903-4913.
14. Hajela R.K., Atchison W.D. The proteins synaptotagmin and syntaxin are not general targets of Lambert-Eaton myasthenic syndrome autoantibody. J. Neurochem. 64:1995;1245-1251.
15. Kim Y.I., Longacher J.M., Viglione M.P. ω-Agatoxin IVA blocks evoked quantal transmitter release at the mammalian neuromuscular junction. Molec. Biol. Cell. 4(Suppl.):1993;A428.
16. Kim Y.I., Neher E. IgG from patients with Lambert-Eaton syndrome blocks voltage-dependent calcium channels. Science. 239:1988;405-408.
17. Lambert E.H., Eaton L.M., Rooke E.D. Defect of neuromuscular conduction associated with malignant neoplasm. Am. J. Physiol. 187:1956;612-613.
18. Lennon V.A., Lambert E.H. Autoantibodies bind solubilized calcium-ω-conotoxin complexes from small cell lung carcinoma: a diagnostic aid for Lambert-Eaton myasthenic syndrome. Mayo Clin. Proc. 64:1989;1498-1504.
19. Lévêque C., Hoshino T., David P., Shoji-Kasai Y., Leys K., Omori A., Lang B., El Far O., Sato K., Martin-Moutôt N., Newsom-Davis J., Takahashi M., Seagar M.J. The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen. Proc. natn. Acad. Sci. U.S.A. 89:1992;3625-3629.
20. Leys K., Lang B., Newsom-Davis J. Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. Ann. Neurol. 29:1991;307-314.
21. 2+ channel. J. biol. Chem. 271:1996;13804-13810.
22. 2+ channels by Lambert-Eaton myasthenic syndrome (LEMS) antibodies in rat insulinoma RINm5F cells. Fedn Eur. biochem. Socs Lett. 387:1996;47-52.
23. Martin-Moutot N., Leveque C., Sato K., Kato R., Takahashi M., Seagar M. Properties of omega conotoxin MVIIC receptors associated with alpha 1A calcium channel subunits in rat brain. Fedn Eur. biochem. Socs Lett. 366:1995;21-25.
24. Martin-Moutot N., Charvin N., Leveque C., Sato K., Nishiki T., Kozaki S., Takahashi M., Seagar M. Interaction of SNARE complexes with P/Q-type calcium channels in rat cerebellar synaptosomes. J. biol. Chem. 271:1996;6567-6570.
25. Motomura M., Johnston I., Lang B., Vincent A., Newsom-Davis J. An improved diagnostic assay for Lambert-Eaton myasthenic syndrome. J. Neurol. Neurosurg. Psychiat. 58:1995;85-87.
26. O'Neill J.H., Murray N.M. F., Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. Brain. 111:1988;577-596.
27. Peers C., Lang B., Newsom-Davis J., Wray D.W. Selective action of myasthenic syndrome antibodies on calcium channels in a rodent neuroblastoma×glioma cell line. J. Physiol. 421:1990;293-308.
28. 2+ flux in a human small cell carcinoma line. Nature. 317:1985;737-739.
29. Rosenfeld M.R., Wong E., Dalmau J., Manley G., Posner J.B., Sher E., Furneaux H.M. Cloning and characterization of a Lambert-Eaton myasthenic syndrome antigen. Ann. Neurol. 33:1993;113-120.
30. 2+ channels. J. biol. Chem. 271:1996;3207-3212.
31. Sher E., Gotti C., Canal N., Scopetta C., Evoli A., Clementi F. Specificity of calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome. Lancet. 2:1989;640-643.
32. Suenaga A., Shirabe S., Nakamura T., Motomura M., Tsujihata M., Matsuo H., Kataoka Y., Niwa M., Itoh M., Nagataki S. Specificity of autoantibodies reacting with omega-conotoxin MVIIC-sensitive calcium channel in Lambert-Eaton myasthenic syndrome. Muscle Nerve. 19:1996;1166-1168.
33. Takahashi T., Momiyama A. Different types of calcium channels mediate central synaptic transmission. Nature. 366:1993;156-158.
34. Takamori M., Hamada T., Komai K., Takahashi M., Yoshida A. Synaptotagmin can cause an immune-mediated model of Lambert-Eaton myasthenic syndrome in rats. Ann. Neurol. 35:1994;74-80.
35. Takamori M., Takahashi M., Yasukawa Y., Iwasa K., Nemoto Y., Suenaga A., Nagataki S., Nakamura T. Antibodies to recombinant synaptotagmin and calcium channel subtypes in Lambert-Eaton myasthenic syndrome. J. neurol. Sci. 133:1995;95-101.
36. Uchitel O.D., Protti D.A., Sanchez V., Cherksey B.D., Sugimori M., Llinas R. P-type voltage-dependent calcium channel mediates presynaptic calcium influx and transmitter release in mammalian synapses. Proc. natn. Acad. Sci. U.S.A. 89:1992;3330-3333.
37. Viglione M.P., Oshaughnessy T.J., Kim Y.I. Inhibition of calcium currents and exocytosis by Lambert-Eaton syndrome antibodies in human lung cancer cells. J. Physiol. 488:1995;303-317.
38. 2+ channels in supporting hippocampal synaptic transmission. Science. 264:1994;107-111.
39. 2+ channel complex purified from brain. Science. 261:1993;486-489.